The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis
Description
Background: It seems that patients with multiple sclerosis (MS) are at a higher risk for coronavirus disease 2019 (COVID-19) implications due to being subjected to immunomodulatory or immunosuppressive treatments. Besides, obesity as a risk factor